Skip to main content
. 2016 Oct 4;6(10):e909. doi: 10.1038/tp.2016.179

Figure 3.

Figure 3

Expression levels of RGS2, DLGAP1, BCHE, SNORD116-13, DNASE1L3, SIRT1 and SARM1 in lymphoblastoid cells lines (LCLs) of Alzheimer's disease (AD) patients and healthy controls. The values were determined by real-time PCR; fold-difference (FD) values are shown for 2−ΔCT (see the 'Materials and methods' section). (a) RSG2: AD (N=28) and control (N=32). (b) DLGAP1: AD (N=24) and control (N=28). (c) BCHE: AD (N=27) and control (N=28). (d) SNORD116-13: AD (N=28) and control (N=32). (e) DNASE1L3: AD (N=28) and control (N=32). (f) SIRT1: AD (N=28) and control (N=32). (g) SARM1: AD (N=28) and control (N=32).